Particle.news
Download on the App Store

Novo Nordisk Cuts Wegovy and Ozempic Cash Prices to $349, Launches $199 Intro Offer

The move accelerates the White House pricing deal to expand access through self-pay channels.

Overview

  • Most Wegovy and Ozempic doses now cost $349 a month for cash payers, while the 2‑milligram Ozempic dose remains $499.
  • New self-pay patients can purchase the two lowest doses for $199 per month for their first two months, with the offer available through March 31, 2026.
  • Discounts are available through Wegovy.com and Ozempic.com, NovoCare, and partners such as GoodRx, Costco and WeightWatchers, with access at more than 70,000 pharmacies.
  • The cuts come ahead of the TrumpRx rollout in early 2026, where prices are slated to start near $350 and trend toward about $245, with Medicare and Medicaid net prices set at $245.
  • Eli Lilly’s Zepbound is priced at $299 for the lowest dose and up to $449 at higher doses, while clinicians caution that reduced cash prices may still leave many patients struggling to afford treatment.